ASNDAscendis Pharma A/S
Is it safe?
Nothing alarming, nothing pristine: insiders quiet and typical volatility.
Insiders were net sellers (-$380K, 90 days to Oct 22, 2026), selling is often routine.
Moderate price swings, typical volatility. Worst drawdown -62% · now 12% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can ASND take a bad year?
The deepest fall in ASND's price history on file is −62%; it is 12% below its high today.
Worst drawdown on file · −12% today
- Interest cover
- none
Interest cover · no operating profit to pay the interest bill from
- Annualised volatility
- 40%
Annualised volatility · S&P 500 16% · roughly twice as jumpy as the market
Details›
- Cash and short-term investments
- $616M
- Operating profit, trailing twelve months
- −$136M
- Annualised volatilitytwo years of daily moves
- 40%
- Worst drawdown on file
- −62%
- Below its 52-week high
- 12%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
How far can it fall?
How much the price moves, how deep and how long its falls have run, and what each unit of risk has paid.